
3 Credit Rating, Registrar and Life Insurance Stocks With a Strong Future Roadmap: CARE Ratings, KFin Technologies and HDFC Life Insurance Company
CARE Ratings Rs 1,519.20, P/E 25.70. KFin Rs 866.00, P/E 42.41. HDFC Life Rs 559.25, P/E 59.96. Closing prices of 12 Oct 2026.
Updated: 13 Oct 2026 • 9:21 am
Posted by:

Quick Answer
Credit rating, registrar and life insurance stocks with the clearest long-term roadmaps today include CARE Ratings in credit ratings and analytical services, KFin in registrar, mutual fund servicing and issuer solutions and HDFC Life in protection, savings, annuity and group life insurance. FY26 revenue growth was 16.5% at CARE Ratings, 19.1% at KFin and 3.1% at HDFC Life. P/E stands at 25.70 for CARE Ratings (industry 33.32), 42.41 for KFin (industry 42.30) and 59.96 for HDFC Life (industry 10.30). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company's risks need equal attention.
Credit rating, registrar and life insurance stocks give investors exposure to services that support bond markets, fund investors and household financial planning. Fee growth, premium growth and margins decide how much of that demand turns into profit.
This list covers three credit rating, registrar and life insurance stocks: CARE Ratings for credit ratings and analytical services, KFin Technologies for registrar, mutual fund servicing and issuer solutions and HDFC Life Insurance Company for protection, savings, annuity and group life insurance. Every figure comes from the latest reported financials and the 12 October 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Credit Rating, Registrar and Life Insurance Stocks?
Credit rating, registrar and life insurance stocks are shares of companies that rate borrowers, service fund investors or sell life insurance. Results depend on fee growth, premium growth and margins, so fees and margins separate the stronger names.
Credit Rating, Registrar and Life Insurance Stocks at a Glance
The table compares size, valuation, return on equity and debt for the three credit rating, registrar and life insurance stocks as of the 12 Oct 2026 close.
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE | Debt to Equity |
|---|---|---|---|---|---|---|
| CARE Ratings | 1,519.20 | 4,631 | 25.70 | 33.32 | 18.36% | 0.03 |
| KFin Technologies | 866.00 | 14,487 | 42.41 | 42.30 | 20.54% | 0.03 |
| HDFC Life Insurance Company | 559.25 | 118,406 | 59.96 | 10.30 | 10.10% | 0.16 |
Among financial services stocks, HDFC Life trades at a premium to the industry P/E, while CARE Ratings trades at a discount.
Why Do Credit Rating, Registrar and Life Insurance Stocks Have a Strong Roadmap in India?
Credit rating, registrar and life insurance stocks have a strong roadmap in India because growth in bond markets, mutual fund investing and life cover keeps lifting demand for rating, servicing and insurance firms. Three drivers stand out.
- Debt markets: More borrowers seek ratings to raise funds.
- Fund investing: Rising mutual fund folios need servicing partners.
- Life cover: Protection and savings plans reach more families.
CARE Ratings: Rating Fees Anchor the Roadmap
CARE Ratings' roadmap rests on a credit rating agency that rates debt instruments and provides analytical services to borrowers and lenders, with rating fees linked to debt raised by companies supporting earnings.
Revenue grew from Rs 274.82 crore in FY22 to Rs 527.89 crore in FY26, a 92.1% rise, and FY26 revenue was 16.5% higher than FY25. FY26 net profit rose 24.1% to Rs 173.70 crore. Over four years, net profit rose from Rs 76.83 crore in FY22 to Rs 173.70 crore. In Q1 FY27, revenue grew 17.5% to Rs 126.48 crore, and net profit rose 24.5% to Rs 32.99 crore. Operating margin was 53.32% in FY26 and 44.26% in Q1 FY27 against 44.12% a year earlier.
Debt to equity is 0.03 and return on equity is 18.36%. FY26 operating cash flow was Rs 147.57 crore against capital expenditure of Rs 8.30 crore. CARE Ratings paid a dividend of Rs 22 per share for FY26, a yield of 1.43%. At a P/E of 25.70 against an industry P/E of 33.32, the stock trades below its industry multiple.
What to watch: Q1 FY27 operating margin was 44.26% against 53.32% for FY26, so margin stability is the figure to follow as volumes grow.
KFin Technologies: Investor Services Platform Anchors the Roadmap
KFin's roadmap rests on registrar and transfer services, mutual fund servicing and issuer solutions, with rising investor participation supporting service volumes.
Revenue grew from Rs 645.56 crore in FY22 to Rs 1,343.92 crore in FY26, a 108.2% rise, and FY26 revenue was 19.1% higher than FY25. FY26 net profit rose 3.3% to Rs 343.71 crore. Over four years, net profit rose from Rs 148.55 crore in FY22 to Rs 343.71 crore. In Q1 FY27, revenue grew 29.1% to Rs 366.90 crore. Operating margin was 42.96% in FY26.
Debt to equity is 0.03 and return on equity is 20.54%. FY26 operating cash flow was Rs 369.60 crore against capital expenditure of Rs 110.92 crore. KFin paid a dividend of Rs 12 per share for FY26, a yield of 1.43%. At a P/E of 42.41 against an industry P/E of 42.30, the stock trades in line with its industry multiple.
What to watch: The P/E of 42.41 is a modest premium to the industry P/E of 42.30, so the next quarters' growth is the figure to follow.
HDFC Life Insurance Company: Life Insurance Premiums Anchor the Roadmap
HDFC Life's roadmap rests on life insurance covering protection, savings, annuity and group products, with rising insurance penetration supporting premiums.
Revenue grew from Rs 67,891.60 crore in FY22 to Rs 100,355.41 crore in FY26, a 47.8% rise, and FY26 revenue was 3.1% higher than FY25. FY26 net profit rose 5.6% to Rs 1,912.32 crore. Over four years, net profit rose from Rs 1,326.93 crore in FY22 to Rs 1,912.32 crore. In Q1 FY27, revenue grew 14.5% to Rs 33,929.83 crore, and net profit rose 11.5% to Rs 611.19 crore.
Debt to equity is 0.16 and return on equity is 10.10%. HDFC Life paid a dividend of Rs 2.1 per share for FY26, a yield of 0.38%. At a P/E of 59.96 against an industry P/E of 10.30, the stock trades above its industry multiple.
What to watch: The P/E of 59.96 sits above the industry P/E of 10.30, so earnings delivery matters for the valuation.
Best Credit Rating, Registrar and Life Insurance Stocks in India: CARE Ratings vs KFin vs HDFC Life on Key Financials
Among the best credit rating, registrar and life insurance stocks in India, CARE Ratings leads on FY26 net profit growth and the lowest P/E; KFin leads on FY26 revenue growth and Q1 FY27 revenue growth; HDFC Life ranks second on FY26 net profit growth. The table puts the numbers side by side.
| Metric | CARE Ratings | KFin | HDFC Life |
|---|---|---|---|
| FY26 revenue (Rs Cr) | 527.89 | 1,343.92 | 100,355.41 |
| FY26 revenue growth | 16.5% | 19.1% | 3.1% |
| FY26 net profit (Rs Cr) | 173.70 | 343.71 | 1,912.32 |
| FY26 net profit growth | 24.1% | 3.3% | 5.6% |
| Q1 FY27 revenue growth (YoY) | 17.5% | 29.1% | 14.5% |
| Return on equity | 18.36% | 20.54% | 10.10% |
| P/E ratio | 25.70 | 42.41 | 59.96 |
| Debt to equity | 0.03 | 0.03 | 0.16 |
| Dividend yield | 1.43% | 1.43% | 0.38% |
Financial services earnings follow fee growth, premium growth and margins, so full-year numbers and quarterly trends together give a better view.
How to Evaluate Credit Rating, Registrar and Life Insurance Stocks to Buy Before You Invest
A short checklist keeps the research consistent when you screen credit rating, registrar and life insurance stocks and shortlist credit rating, registrar and life insurance stocks to buy.
- Compare each stock's P/E with its industry P/E, which differs by company here.
- Check revenue growth, margins and return on equity together.
- Check whether revenue growth is turning into profit growth, not only sales.
- Read loan growth against funding costs to see how growth is financed.
- Watch debt to equity and interest cover before sizing a position.
- Spread exposure across companies and business lines instead of one demand cycle.
Check the Univest Screener for live data on these credit rating, registrar and life insurance stocks
Risks to Consider Before Investing in Credit Rating, Registrar and Life Insurance Stocks
- Valuation: HDFC Life trades at 59.96 times earnings against an industry multiple of 10.30.
- Market activity: Slower capital markets can affect fee income.
- Regulation: Rule changes can affect pricing and product mix.
- Quarterly trends: A single weak quarter can change near-term earnings, so track results every quarter.
Download the Univest iOS App or Univest Android App to track CARE Ratings, KFin and HDFC Life live.
Final Take: Which Stock Has the Strongest Roadmap?
These three financial services stocks cover credit ratings, registrar services and life insurance. CARE Ratings leads on FY26 net profit growth and the lowest P/E; KFin leads on FY26 revenue growth and Q1 FY27 revenue growth; HDFC Life ranks second on FY26 net profit growth.
Across credit rating, registrar and life insurance stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the credit rating, registrar and life insurance stocks to buy discussed here.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Credit Rating, Registrar and Life Insurance Stocks
Which are the best credit rating, registrar and life insurance stocks in India with a strong roadmap?
Ans. CARE Ratings, KFin Technologies and HDFC Life Insurance Company stand out for their roadmaps in credit ratings, registrar services and life insurance. FY26 revenue growth was 16.5% at CARE Ratings, 19.1% at KFin and 3.1% at HDFC Life, and return on equity ranges from 10.10% to 20.54%.
Is CARE Ratings a good stock to buy now?
Ans. CARE Ratings has a debt to equity ratio of 0.03, a return on equity of 18.36% and a P/E of 25.70 against an industry P/E of 33.32. Valuation, market activity and regulation move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.
What is the P/E ratio of CARE Ratings, KFin and HDFC Life?
Ans. The P/E ratio is 25.70 for CARE Ratings (industry 33.32), 42.41 for KFin (industry 42.30) and 59.96 for HDFC Life (industry 10.30). Only KFin and HDFC Life trade at or above the industry multiple.
Which of these credit rating, registrar and life insurance stocks has the highest return on equity?
Ans. KFin Technologies has the highest return on equity at 20.54%, followed by CARE Ratings at 18.36% and HDFC Life Insurance Company at 10.10%.
What are the risks of investing in credit rating, registrar and life insurance stocks?
Ans. The main risks are valuation, market activity, regulation and quarterly trends. HDFC Life trades at 59.96 times earnings against an industry multiple of 10.30.
How did CARE Ratings, KFin and HDFC Life perform in Q1 FY27?
Ans. CARE Ratings reported revenue of Rs 126.48 crore, up 17.5% year on year, and net profit rose 24.5% to Rs 32.99 crore. KFin Technologies reported revenue of Rs 366.90 crore, up 29.1% year on year. HDFC Life Insurance Company reported revenue of Rs 33,929.83 crore, up 14.5% year on year, and net profit rose 11.5% to Rs 611.19 crore.
Do credit rating, registrar and life insurance stocks pay dividends?
Ans. Yes, all three companies pay dividends. The dividend yield is 1.43% for CARE Ratings, 1.43% for KFin and 0.38% for HDFC Life, based on dividends declared for FY26.
How can I invest in credit rating, registrar and life insurance stocks in India?
Ans. You can buy credit rating, registrar and life insurance stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.
Recent Articles

3 Smart Meter, City Gas and Thermal Power Stocks With a Strong Future Roadmap: HPL Electric & Power, IRM Energy and Adani Power
13 October 2026

3 Vaccine, Formulation and Pharmacy Chain Stocks With a Strong Future Roadmap: GlaxoSmithKline Pharmaceuticals, Lincoln Pharmaceuticals and Medplus Health Services
13 October 2026

3 Tourism, Hotel and Television Network Stocks With a Strong Future Roadmap: India Tourism Development Corporation, Oriental Hotels and Sun TV Network
13 October 2026

3 Digital Operations, E-Governance and Auto Marketplace Stocks With a Strong Future Roadmap: Datamatics Global Services, Protean eGov Technologies and CarTrade Tech
13 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
3 Smart Meter, City Gas and Thermal Power Stocks With a Strong Future Roadmap: HPL Electric & Power, IRM Energy and Adani Power
3 Vaccine, Formulation and Pharmacy Chain Stocks With a Strong Future Roadmap: GlaxoSmithKline Pharmaceuticals, Lincoln Pharmaceuticals and Medplus Health Services
3 Tourism, Hotel and Television Network Stocks With a Strong Future Roadmap: India Tourism Development Corporation, Oriental Hotels and Sun TV Network
3 Digital Operations, E-Governance and Auto Marketplace Stocks With a Strong Future Roadmap: Datamatics Global Services, Protean eGov Technologies and CarTrade Tech
3 Surface Treatment, Pigment and Sugar Group Stocks With a Strong Future Roadmap: Grauer & Weil (India), Ultramarine & Pigments and EID Parry (India)

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





